Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - pseudoephedrine hydrochloride, quantity: 30 mg; dextromethorphan hydrobromide monohydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, film coated - excipient ingredients: carnauba wax; purified water; povidone; magnesium stearate; hydrogenated vegetable oil; croscarmellose sodium; microcrystalline cellulose; pregelatinised maize starch; sodium starch glycollate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - provides temporary relief of nagging cough and discomfort associated with cold and flu: relieves blocked noses, dries runny noses, provides temporary relief of cough and headache, relieves body aches and pains, reduces fever.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

juno pc holdings pty limited - phentermine hydrochloride, quantity: 49.7 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; polyvinyl alcohol; macrogol 3350; brilliant scarlet 4r aluminium lake - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

juno pc holdings pty limited - phentermine hydrochloride, quantity: 37.275 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

juno pc holdings pty limited - phentermine hydrochloride, quantity: 18.6375 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide yellow; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

juno pc holdings pty limited - phentermine hydrochloride, quantity: 49.7 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; polyvinyl alcohol; macrogol 3350; brilliant scarlet 4r aluminium lake - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

juno pc holdings pty limited - phentermine hydrochloride, quantity: 37.275 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

juno pc holdings pty limited - phentermine hydrochloride, quantity: 18.6375 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide yellow; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

Bahrain - engelska - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - cetirizine dihydrochloride-5mg, pseudoephedrine hydrochloride-120mg - prolonged released tablets

Kenya - engelska - Pharmacy and Poisons Board

msd (pty) ltd 117 16th road halfway house south africa - desloratadine and pseudoephedrine sulfate - tablet - 2.5mg desloratadine and 120mg pseudoephedrine… - antihistamines for systemic use: aminoalkyl ethers

Irland - engelska - HPRA (Health Products Regulatory Authority)

diapharm gmbh & co. kg - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200/30 milligram(s) - other cold preparations